Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Volunteer subjects with interstitial lung disease in whom a surgical lung biopsy is planned for diagnostic investigation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after biopsy (up to 24months)
Awards & highlights
Study Summary
This trial evaluates the safety and effectiveness of two procedures for diagnosing interstitial lung disease.
Eligible Conditions
- Interstitial Lung Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after biopsy (up to 24months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after biopsy (up to 24months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Overall diagnostic yield of cryobiopsy specimens in interstitial lung disease
Secondary outcome measures
Complication rate of transbronchial cryobiopsy procedure
Inter-observer agreement for cryobiopsy specimens
Number of diagnostic specimens of cryoTBB in comparison with surgical lung biopsy specimen
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: CryobiopsyExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Laval UniversityLead Sponsor
418 Previous Clinical Trials
172,232 Total Patients Enrolled
Antoine Delage, MDCMStudy ChairInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger